Imperial Innovation Fund, alongside Johnson & Johnson Foundation and Newtown Partners, invested USD 1.5M in Ghana-based health-tech startup Redbird to support its mission of improving healthcare accessibility through rapid diagnostic testing.
Target Information
Redbird, a Ghana-based health technology startup, empowers patients to efficiently manage their health through quick medical tests available at local community pharmacies. With a mission to revolutionize healthcare accessibility, Redbird allows users to access their digital health records via a dedicated application, ensuring that they can monitor their health effortlessly.
Founded in 2018 by Patrick Beattie and his team, Redbird offers ten different rapid tests performed at over 350 partner pharmacies across Ghana. These tests provide instant results that are stored in a personal health record accessible through the Redbird app, enhancing patient-centric healthcare delivery. Moreover, the platform encourages information sharing with healthcare professionals, given patient consent, to provide a comprehensive view of individual health histories.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare landscape in Ghana is undergoing significant transformation, particularly in the health-tech sector. Rapid advancements in technology and increasing smartphone penetration are paving the way for innovative solutions aime
Similar Deals
Kurma Partners, WE Life Sciences, Bpifrance, Argobio, Angelini Ventures, CARMA Fund, Capital Grand Est, Sambrinvest → Elkedonia
2025
SC Launch Inc. → NeuroQuest
2025
Imperial Innovation Venture Fund
invested in
Redbird
in 2021
in a Seed Stage deal
Disclosed details
Transaction Size: $2M